Skip to main content
SpringerLink
Log in

Imaging of Renal Cancer

  • Chapter
  • First Online:
Renal Cancer

Abstract

The global incidence of adult renal cancer continues to increase, with little change in the predominant cell type, renal cell carcinoma. The rise in incidence is in part due to an increasing number of imaging studies of the abdomen and pelvis performed for a variety of reasons, and therefore, incidental diagnosis. The majority of cases are localized. This has a favorable prognostic impact, since cancer may be detected at an earlier stage.

The various imaging modalities including ultrasound, CT, and MRI available for the detection, diagnosis, staging, and surveillance of adult renal cancer are discussed in this chapter.

Future directions of imaging, including antibody-directed PET imaging, and functional imaging evaluation are also considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society. Cancer facts & figures 2018. Atlanta: American Cancer Society; 2018.

    Google Scholar 

  2. Cho E, Adami HO, Lindblad P. Epidemiology of renal cell cancer. Hematol Oncol Clin North Am. 2011;25(4):651–65.

    Article  PubMed  Google Scholar 

  3. Rossi SH, Klatte T, Usher-Smith J, et al. Epidemiology and screening for renal cancer. World J Urol. 2018; https://doi.org/10.1007/s00345-018-2286-7.

  4. Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z, Shariat SF, Montorsi F, Patard JJ, Perrotte P, Karakiewicz PI. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol. 2011;59(1):135–41.

    Article  PubMed  Google Scholar 

  5. Agarwal R, Bergey M, Sonnad S, Butowsky H, Bhargavan M, Bleshman MH. Inpatient CT and MRI utilization: trends in the academic hospital setting. J Am Coll Radiol. 2010;7(12):949–55.

    Article  PubMed  Google Scholar 

  6. Herts B, Silverman S, Hindman N, et al. Management of the Incidental Renal Mass on CT: a white paper of the ACR incidental findings committee. J Am Coll Radiol. 2018;15(2):264–73.

    Article  PubMed  Google Scholar 

  7. Capitanio U, Montorsi F. Renal Cancer. Lancet. 2016;387(10021):894–906.

    Article  PubMed  Google Scholar 

  8. McIntosh AG, Ristau BT, Ruth K, et al. Active surveillance for localized renal masses: tumor growth, delayed intervention rates, and >5-yr clinical outcomes. Eur Urol. 2018;74(2):157–64.

    Article  PubMed  Google Scholar 

  9. Klatte T, Marberger M. High-intensity focused ultrasound for the treatment of renal masses: current status and future potential. Curr Opin Urol. 2009;19(2):188–91.

    Article  PubMed  Google Scholar 

  10. Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–24.

    Article  Google Scholar 

  11. Ginzburg S, Tomaszewski J, Kutikov A, et al. Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy. Nat Rev Urol. 2017;14(11):669–82.

    Article  PubMed  Google Scholar 

  12. Long CJ, Kutikov A, Canter DJ, et al. Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised? BJU Int. 2011;107(9):1376–80.

    Article  PubMed  Google Scholar 

  13. O'Connor OJ, McSweeney SE, Maher MM. Imaging of hematuria. Radiol Clin N Am. 2008;46(1):113–32, vii.

    Article  PubMed  Google Scholar 

  14. Bai X, Wu CL. Renal cell carcinoma and mimics: pathologic primer for radiologists. AJR Am J Roentgenol. 2012;198(6):1289–93.

    Article  PubMed  Google Scholar 

  15. Mucksavage P, Ramchandani P, Malkowicz SB, Guzzo TJ. Is ultrasound imaging inferior to computed tomography or magnetic resonance imaging in evaluating renal mass size? Urology. 2012;79(1):28–31.

    Article  PubMed  Google Scholar 

  16. Gerst S, Hann LE, Li D, Gonen M, Tickoo S, Sohn MJ, Russo P. Evaluation of renal masses with contrast-enhanced ultrasound: initial experience. AJR Am J Roentgenol. 2011;197(4):897–906.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Dietrich CF, Averkiou M, Nielsen MB, et al. How to perform Contrast-Enhanced Ultrasound (CEUS). Ultrasound Int Open. 2018;4(1):E2–E15.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Chang EH, Chong WK, Kasoji SK, et al. Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease. BMC Nephrol. 2017;18:266.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J, Hammers L, Taylor C, Rosenfield AT. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 1988;169(2):363–5.

    Article  CAS  PubMed  Google Scholar 

  20. Pahernik S, Ziegler S, Roos F, Melchior SW, Thüroff JW. Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol. 2007;178(2):414–7; discussion 416-7.

    Article  PubMed  Google Scholar 

  21. Guðmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberg B, Swedish Kidney Cancer Quality Register Group. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data. Eur Urol. 2011;60(5):975–82.

    Article  PubMed  Google Scholar 

  22. Marberger M, Schatzl G, Cranston D, Kennedy JE. Extracorporeal ablation of renal tumours with high-intensity focused ultrasound. BJU Int. 2005;95(Suppl 2):52–5.

    Article  PubMed  Google Scholar 

  23. Tada S, Yamagishi J, Kobayashi H, Hata Y, Kobari T. The incidence of simple renal cyst by computed tomography. Clin Radiol. 1983;34(4):437–9.

    Article  CAS  PubMed  Google Scholar 

  24. Israel GM, Silverman SG. The incidental renal mass. Radiol Clin N Am. 2011;49(2):369–83.

    Article  PubMed  Google Scholar 

  25. Silverman SG, Israel GM, Trinh QD. Incompletely characterized incidental renal masses: emerging data support conservative management. Radiology. 2015;275(1):28–42.

    Article  PubMed  Google Scholar 

  26. Catalano C, Fraioli F, Laghi A, Napoli A, Pediconi F, Danti M, Nardis P, Passariello R. High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR Am J Roentgenol. 2003;180(5):1271–7.

    Article  CAS  PubMed  Google Scholar 

  27. Flocks RH, Kadesky MC. Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more. J Urol. 1958;79(2):196–201.

    Article  CAS  PubMed  Google Scholar 

  28. Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol. 1963;89:37–42.

    Article  CAS  PubMed  Google Scholar 

  29. Hartman DS, Choyke PL, Hartman MS. From the RSNA refresher courses: a practical approach to the cystic renal mass. Radiographics. 2004;24(Suppl 1):S101–15.

    Article  PubMed  Google Scholar 

  30. Bosniak MA. The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. Radiology. 1991;179(2):307–17.

    Article  CAS  PubMed  Google Scholar 

  31. Bosniak MA. The current radiological approach to renal cysts. Radiology. 1986;158(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  32. Bosniak MA. The Bosniak renal cyst classification: 25 years later. Radiology. 2012;262(3):781–5.

    Article  PubMed  Google Scholar 

  33. Schoots IG, Zaccai K, Hunink MG, Verhagen PCM. Bosniak classification for complex Renal Cysts reevaluated: a systematic review. J Urol. 2017;198(1):12–21.

    Article  PubMed  Google Scholar 

  34. Kim JK, Kim TK, Ahn HJ, Kim CS, Kim KR, Cho KS. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol. 2002;178(6):1499–506.

    Article  PubMed  Google Scholar 

  35. Herts BR, Coll DM, Novick AC, Obuchowski N, Linnell G, Wirth SL, Baker ME. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol. 2002;178(2):367–72.

    Article  PubMed  Google Scholar 

  36. Kaza RK, Ananthakrishnan L, Kambadakone A, Platt JF. Update of dual-energy CT applications in the genitourinary tract. AJR Am J Roentgenol. 2017;208(6):1185–92.

    Article  PubMed  Google Scholar 

  37. Lam JS, Leppert JT, Figlin RA, Belldegrun AS. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep. 2005;6(1):7–18. Review.

    Article  PubMed  Google Scholar 

  38. Levy DA, Slaton JW, Swanson DA, Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol. 1998;159(4):1163–7.

    Article  CAS  PubMed  Google Scholar 

  39. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335(12):865–75. Review.

    Article  CAS  PubMed  Google Scholar 

  40. Scatarige JC, Sheth S, Corl FM, Fishman EK. Patterns of recurrence in renal cell carcinoma: manifestations on helical CT. AJR Am J Roentgenol. 2001;177(3):653–8.

    Article  CAS  PubMed  Google Scholar 

  41. Williamson TJ, Pearson JR, Ischia J, et al. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma. BJU Int. 2016;117(4):555–62.

    Article  PubMed  Google Scholar 

  42. Lam JS, Shvarts O, Pantuck AJ. Changing concepts in the surgical management of renal cell carcinoma. Eur Urol. 2004;45(6):692–705. Review.

    Article  PubMed  Google Scholar 

  43. Kawamoto S, Permpongkosol S, Bluemke DA, Fishman EK, Solomon SB. Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging. Radiographics. 2007;27(2):343–55.

    Article  PubMed  Google Scholar 

  44. Davenport MS, Caoili EM, Cohan RH, Ellis JH, Higgins EJ, Willatt J, Fox GA. MRI and CT characteristics of successfully ablated renal masses: imaging surveillance after radiofrequency ablation. AJR Am J Roentgenol. 2009;192(6):1571–8.

    Article  PubMed  Google Scholar 

  45. Bostwick DG, Murphy GP. Diagnosis and prognosis of renal cell carcinoma: highlights from an international consensus workshop. Semin Urol Oncol. 1998;16(1):46–52. Review.

    CAS  PubMed  Google Scholar 

  46. Beck SD, Patel MI, Snyder ME, Kattan MW, Motzer RJ, Reuter VE, Russo P. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol. 2004;11(1):71–7.

    Article  PubMed  Google Scholar 

  47. Schuster TG, Ferguson MR, Baker DE, Schaldenbrand JD, Solomon MH. AJR papillary renal cell carcinoma containing fat without calcification mimicking angiomyolipoma on CT. Am J Roentgenol. 2004;183(5):1402–4.

    Article  Google Scholar 

  48. Pedrosa I, Sun MR, Spencer M, Genega EM, Olumi AF, Dewolf WC, Rofsky NM. MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics. 2008;28(4):985–1003.

    Article  PubMed  Google Scholar 

  49. Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol. 2010;195(6):W421–7.

    Article  PubMed  Google Scholar 

  50. Inci E, Hocaoglu E, Aydin S, Cimilli T. Diffusion-weighted magnetic resonance imaging in evaluation of primary solid and cystic renal masses using the Bosniak classification. Eur J Radiol. 2012;81(5):815–20.

    Article  PubMed  Google Scholar 

  51. Sasaguri K, Takahashi N. CT and MR imaging for solid renal mass characterization. Eur J Radiol. 2018;99:40–54.

    Article  PubMed  Google Scholar 

  52. Sandrasegaran K, Sundaram CP, Ramaswamy R, Akisik FM, Rydberg MP, Lin C, Aisen AM. Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol. 2010;194(2):438–45.

    Article  PubMed  Google Scholar 

  53. Woo S, Suh CH, Kim SY, Cho JY, Kim SH. Diagnostic performance of DWI for differentiating high- from low-grade clear cell renal cell carcinoma: a systematic review and meta-analysis. AJR Am J Roentgenol. 2017;209(6):W374–81.

    Article  Google Scholar 

  54. Florez E, Fatemi A, Claudio PP, Howard CM. Emergence of Radiomics: novel methodology identifying imaging biomarkers of disease in diagnosis, response, and progression. SM J Clin Med Imaging. 2018;4(1):1019.

    Google Scholar 

  55. Bazak R, Houri M, El Achy S, Kamel S, Refaat T. Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol. 2015;141:769.

    Article  CAS  PubMed  Google Scholar 

  56. Oosterwijk-Wakka JC, Boerman OC, Mulders PF, Oosterwijk E. Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma. Int J Mol Sci. 2013;14(6):11402–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Lau J, Lin K-S, Bénard F. Past, present, and future: development of Theranostic Agents Targeting Carbonic. Anhydrase IX. Theranostics. 2017;7(17):4322.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Smaldone MC, Chen DY, Uzzo RG, Yu M. Molecular imaging of the small renal mass. Urol Oncol. 2011;29(6):589–92.

    Article  PubMed  Google Scholar 

  59. Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology. 2005;236(2):441–50.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Lahey Hospital & Medical Center, Burlington, MA, USA

    Jalil Afnan & Christoph Wald

  2. Section Head Body Imaging, Department of Radiology, Lahey Hospital & Medical Center, Burlington, MA, USA

    Jaclyn A. Therrien

Authors
  1. Jalil Afnan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaclyn A. Therrien
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christoph Wald
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jalil Afnan .

Editor information

Editors and Affiliations

  1. Professor of Urology, Tufts University School of Medicine, Boston, MA, USA

    John A. Libertino

  2. Associate Professor of Urology, Tufts University School of Medicine, Boston, MA, USA

    Jason R. Gee

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Afnan, J., Therrien, J.A., Wald, C. (2020). Imaging of Renal Cancer. In: Libertino, J., Gee, J. (eds) Renal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-24378-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24378-4_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24377-7

  • Online ISBN: 978-3-030-24378-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation